Eloxx Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Eloxx Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2023.
  • Eloxx Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2023 was 248 %.
  • Eloxx Pharmaceuticals, Inc. annual Return On Equity for 2022 was 6.73K %.
  • Eloxx Pharmaceuticals, Inc. annual Return On Equity for 2021 was -270 %, a 40.4% decline from 2020.
  • Eloxx Pharmaceuticals, Inc. annual Return On Equity for 2020 was -192 %, a 61.8% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 248 +790 Jul 1, 2023 Sep 30, 2023
Q2 2023 544 +801 Apr 1, 2023 Jun 30, 2023
Q1 2023 -4.98K -4.72K -1826% Jan 1, 2023 Mar 31, 2023
Q4 2022 6.73K +7K Oct 1, 2022 Dec 31, 2022
Q3 2022 -542 -261 -93% Jul 1, 2022 Sep 30, 2022
Q2 2022 -257 +78 +23.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -259 -16.1 -6.62% Jan 1, 2022 Mar 31, 2022
Q4 2021 -270 -77.7 -40.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -281 -117 -71.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -335 -190 -131% Apr 1, 2021 Jun 30, 2021
Q1 2021 -243 -113 -86.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -192 -73.5 -61.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -164 -44 -36.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 -145 -32.8 -29.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -130 -22.8 -21.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -119 -6.45 -5.73% Oct 1, 2019 Dec 31, 2019
Q3 2019 -120 -0.15 -0.13% Jul 1, 2019 Sep 30, 2019
Q2 2019 -112 +37.3 +25% Apr 1, 2019 Jun 30, 2019
Q1 2019 -107 +171 +61.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -112 +189 +62.7% Oct 1, 2018 Dec 31, 2018
Q3 2018 -120 +497 +80.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 -149 +281 +65.3% Apr 1, 2018 Jun 30, 2018
Q1 2018 -278 Jan 1, 2018 Mar 31, 2018
Q4 2017 -301 Oct 1, 2017 Dec 31, 2017
Q3 2017 -617 Jul 1, 2017 Sep 30, 2017
Q2 2017 -431 Apr 1, 2017 Jun 30, 2017
Q1 2015 -130 -2.67 -2.09% Jan 1, 2015 Mar 31, 2015
Q4 2014 -139 +6.55 +4.49% Oct 1, 2014 Dec 31, 2014
Q3 2014 -74.9 +141 +65.3% Jul 1, 2014 Sep 30, 2014
Q2 2014 -78.3 +138 +63.8% Apr 1, 2014 Jun 30, 2014
Q1 2014 -128 +77.5 +37.8% Jan 1, 2014 Mar 31, 2014
Q4 2013 -146 +45.2 +23.7% Oct 1, 2013 Dec 31, 2013
Q3 2013 -216 -34.8 -19.2% Jul 1, 2013 Sep 30, 2013
Q2 2013 -217 -79.8 -58.4% Apr 1, 2013 Jun 30, 2013
Q1 2013 -205 -45.6 -28.6% Jan 1, 2013 Mar 31, 2013
Q4 2012 -191 Oct 1, 2012 Dec 31, 2012
Q3 2012 -181 Jul 1, 2012 Sep 30, 2012
Q2 2012 -137 Apr 1, 2012 Jun 30, 2012
Q1 2012 -160 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.